Treace Medical Concepts, INC Schedule 13G passive stakes

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 6,364,000 shares, representing 9.79% of the common stock of Treace Medical Concepts, Inc.

John T. Treace reports beneficial ownership of 19.2% of Treace Medical Concepts' common stock as of June 30, 2026.

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 9.85% of Treace Medical Concepts, Inc. common stock as of March 31, 2026.

Bank of America Corporation has reported a beneficial ownership of 3,533,774 shares, representing 5.5% of the outstanding common stock of Treace Medical Concepts, Inc.

Neil Gagnon and affiliated entities, Gagnon Securities LLC and Gagnon Advisors, LLC, reported a combined beneficial ownership of 9.6% in Treace Medical Concepts, Inc. as of December 31, 2025.

William Blair Investment Management, LLC has disclosed a 1.8% beneficial ownership stake in Treace Medical Concepts, Inc. as of December 31, 2025.

Armistice Capital, LLC and Steven Boyd have reported a 9.99% beneficial ownership stake in Treace Medical Concepts, Inc., holding 6,316,000 shares as of September 30, 2025.

William Blair Investment Management, LLC has reported a 5.8% beneficial ownership stake in Treace Medical Concepts, Inc. common stock.

Armistice Capital and Steven Boyd have increased their beneficial ownership in Treace Medical Concepts, Inc. to 9.91% of common stock.

Neil Gagnon and affiliated entities, Gagnon Securities LLC and Gagnon Advisors, LLC, have disclosed beneficial ownership of 6.3% of Treace Medical Concepts, Inc.'s common stock.

Armistice Capital, LLC and Steven Boyd have disclosed a beneficial ownership of 9.92% in Treace Medical Concepts, Inc., holding 6,211,000 shares of common stock as of March 31, 2025.

Armistice Capital, LLC and Steven Boyd have disclosed a beneficial ownership of 9.97% of Treace Medical Concepts, Inc.'s common stock as of December 31, 2024.

Morgan Stanley has filed an amended Schedule 13G, indicating its beneficial ownership in Treace Medical Concepts, Inc. has fallen to 3.4% as of December 31, 2024, no longer exceeding the 5% threshold.